The MRC Centre develops translational research with many studies now progressing into the clinical environment.
Current studies include:

EMPIRIKAL
ReMIND
The ONE Study
OuTSMART
RituxiCAN-C4
Trials of Eculizumab in patients at very high risk of rejection
POWAR
Clinical study of MCMV5322A / MCMV3068A in kidney transplant recipients at high risk for CMV disease

Observational Studies
ATTOM
Outcomes after living donation
The Effects of Expressive Writing on Haemodialysis Patients
Studies in 'acute' kidney injury
Biomarker studies in kidney transplant rejection: KALIBRE
DECISSIONS

For further information about these trials see our leaflet Interventional and observational studies in kidney and liver diseases and transplantation


Clinical Research

Navigate using the menu above to view our featured research or for information on available research support.